Pharmaceuticals Acquisitions in Ohio
Showing 1 transactions.
-
September 16, 2022
- Buyer
- JanOne Inc.
- Target
- Soin Therapeutics LLC
- Industry
- Pharmaceuticals
- Location
- Ohio, United States
- Type
- Buyout
JanOne Inc. has executed a term sheet to acquire Soin Therapeutics LLC and its patent-pending low-dose naltrexone formulation (to be named JAN123) for the treatment of Complex Regional Pain Syndrome (CRPS). The deal is valued at $13 million up front with up to $17 million in additional contingent payments (total up to $30 million); JanOne expects to advance JAN123 into GMP manufacturing and file an IND in 2023.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.